Search
for
Sort by
Research 181–210 of 1000+
- When hair dig into the brain, JAKi , may help!
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Ruxolitinib found to cause eyelash growth: a case report
- Alopecia areata following COVID-19 vaccine: a systematic review
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Biologics in the management of childhood atopic dermatitis
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement